Stroke in Sumatriptan - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Stroke, when it was recovered, drug effectiveness, race, and more among people who take Sumatriptan (sumatriptan succinate). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,341 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On May, 27, 2026

1 person who has Stroke while taking Sumatriptan was studied.

Severity of Stroke:

n/a

When people recovered from Stroke:

n/a

How effective is Sumatriptan:

n/a

Time on Sumatriptan *:

Gender of people when taking Sumatriptan *:

female: 100 %
male: 0.0 %

Age of people when taking Sumatriptan *:

Conditions people have *:

Depression Postmenopausal (depression during menopause is a mood disorder characterized by symptoms of persistent sadness, and apathy, as well as physical symptoms): 1 person, 100.00%
Depression: 1 person, 100.00%

Other drugs people take besides Sumatriptan *:

Wellbutrin: 1 person, 100.00%
Celexa: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and have Stroke?

Check whether Stroke is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Stroke in Sumatriptan

How the study uses the data?

The study is based on sumatriptan succinate (the active ingredients of Sumatriptan). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.